BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8756569)

  • 1. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.
    Gardella TJ; Luck MD; Jensen GS; Schipani E; Potts JT; Jüppner H
    Endocrinology; 1996 Sep; 137(9):3936-41. PubMed ID: 8756569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
    Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
    Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations.
    Carter PH; Petroni BD; Gensure RC; Schipani E; Potts JT; Gardella TJ
    Endocrinology; 2001 Apr; 142(4):1534-45. PubMed ID: 11250934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
    Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
    Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
    N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11.
    Nutt RF; Caulfield MP; Levy JJ; Gibbons SW; Rosenblatt M; McKee RL
    Endocrinology; 1990 Jul; 127(1):491-3. PubMed ID: 2163325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
    Jobert AS; Zhang P; Couvineau A; Bonaventure J; Roume J; Le Merrer M; Silve C
    J Clin Invest; 1998 Jul; 102(1):34-40. PubMed ID: 9649554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis.
    Gensure RC; Carter PH; Petroni BD; Jüppner H; Gardella TJ
    J Biol Chem; 2001 Nov; 276(46):42692-9. PubMed ID: 11553625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line.
    Orloff JJ; Ganz MB; Nathanson MH; Moyer MS; Kats Y; Mitnick M; Behal A; Gasalla-Herraiz J; Isales CM
    Endocrinology; 1996 Dec; 137(12):5376-85. PubMed ID: 8940360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells.
    Offermanns S; Iida-Klein A; Segre GV; Simon MI
    Mol Endocrinol; 1996 May; 10(5):566-74. PubMed ID: 8732687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia.
    Zhang P; Jobert AS; Couvineau A; Silve C
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3365-8. PubMed ID: 9745456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
    Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
    Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor.
    Schipani E; Karga H; Karaplis AC; Potts JT; Kronenberg HM; Segre GV; Abou-Samra AB; Jüppner H
    Endocrinology; 1993 May; 132(5):2157-65. PubMed ID: 8386612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents.
    Carter PH; Jüppner H; Gardella TJ
    Endocrinology; 1999 Nov; 140(11):4972-81. PubMed ID: 10537121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
    Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
    J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone-related peptide stimulates proliferation of highly tumorigenic human SV40-immortalized breast epithelial cells.
    Cataisson C; Lieberherr M; Cros M; Gauville C; Graulet AM; Cotton J; Calvo F; de Vernejoul MC; Foley J; Bouizar Z
    J Bone Miner Res; 2000 Nov; 15(11):2129-39. PubMed ID: 11092394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
    Hoare SR; Usdin TB
    J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes.
    Behar V; Nakamoto C; Greenberg Z; Bisello A; Suva LJ; Rosenblatt M; Chorev M
    Endocrinology; 1996 Oct; 137(10):4217-24. PubMed ID: 8828480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bone-derived ROS 17/2.8 cells with dexamethasone and pertussis toxin enables detection of partial agonist activity for parathyroid hormone antagonists.
    McKee RL; Caulfield MP; Rosenblatt M
    Endocrinology; 1990 Jul; 127(1):76-82. PubMed ID: 2163326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.